Acetaminophen and Omniscan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acetaminophen (acetaminophen) and Omniscan (gadodiamide). Common drug interactions include mobility decreased among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Acetaminophen and Omniscan. It is created by eHealthMe based on reports of 83 people who take the same drugs from the FDA, and is updated regularly.

What is Acetaminophen?

Acetaminophen has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 183,077 Acetaminophen users. Check the latest studies of Acetaminophen.

What is Omniscan?

Omniscan has active ingredients of gadodiamide. eHealthMe is studying from 6,169 Omniscan users. Check the latest studies of Omniscan.

On Jul, 13, 2026

83 people who take Acetaminophen and Omniscan together, and have interactions are studied.

Acetaminophen and Omniscan drug interactions.

What are the common drug interactions of Acetaminophen and Omniscan, by gender? *:

female:

Mobility decreased (ability to move is reduced)
Joint range of motion decreased (disease of joint movement)
Skin hypertrophy (skin cells enlarges)
Skin exfoliation (removal of the oldest dead skin cells)
Erythema (redness of the skin)
Emotional distress
Skin discolouration (change of skin colour)
Anxiety
Pruritus (severe itching of the skin)
Dry skin

male:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Oedema peripheral (superficial swelling)
Muscular weakness (muscle weakness)
Hypoaesthesia (reduced sense of touch or sensation)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Skin discolouration (change of skin colour)
Anxiety
Scar
Fatigue (feeling of tiredness)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)

What are the common drug interactions of Acetaminophen and Omniscan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Discomfort
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Metaplasia (change in the type of adult cells in a tissue to a form abnormal for that tissue)
Mobility decreased (ability to move is reduced)
Myocardial fibrosis (a condition in which the heart's muscle cells are impaired)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain in extremity
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Skin induration (an abnormally hard spot or area on the skin)
Skin tightness

20-29:

n/a

30-39:

General physical health deterioration (weak health status)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Skin fibrosis (fibrous tissue formation on skin)
Skin hypertrophy (skin cells enlarges)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Skin induration (an abnormally hard spot or area on the skin)
Mobility decreased (ability to move is reduced)
Scar
Deformity (disfigurement)
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)

40-49:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Depression
Erythema (redness of the skin)
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
General physical health deterioration (weak health status)
Joint contracture (a permanent shortening of a muscle or joint)
Joint range of motion decreased (disease of joint movement)
Joint stiffness
Joint swelling
Mobility decreased (ability to move is reduced)

50-59:

Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Peripheral coldness
Sclerodactylia (disabling trophic changes and deformities of the hands and fingers)
Skin fissures (a crack in the skin)
Skin hypopigmentation (loss of skin colour)
Skin wrinkling (wrinkle on skin)
Dysstasia (difficulty in standing)
Pain of skin
Deformity (disfigurement)
Excoriation (to tear or wear off the skin of)

60+:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Oedema peripheral (superficial swelling)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Skin hypertrophy (skin cells enlarges)
Skin tightness
Hypoaesthesia (reduced sense of touch or sensation)
Pain in extremity
Pruritus (severe itching of the skin)
Rash
Back pain

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 36 people, 43.37%
Stress And Anxiety: 15 people, 18.07%
Nausea (feeling of having an urge to vomit): 12 people, 14.46%
Itching: 12 people, 14.46%
High Blood Cholesterol: 12 people, 14.46%
Herpes Zoster: 12 people, 14.46%
Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 12 people, 14.46%
Device Related Infection: 12 people, 14.46%
Depression: 12 people, 14.46%
Nuclear Magnetic Resonance Imaging Abdominal: 10 people, 12.05%

* Approximation only. Some reports may have incomplete information.

Do you take Acetaminophen and Omniscan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously